Clinical trials: OHSS, open to volunteers
Infertility, Sterility
Real-world Evidence on Follitropin Delta Individual Dosing
As part of the in vitro fertilisation treatment, ovarian stimulation is routinely performed. For this purpose, FSH preparations are used.
- Trial name
- NCT05173597
- Testing
- Follitropin delta
- Where
- Germany
- Volunteers
- 850 people
- Sponsor
- University of Luebeck
Gynecologic Disease
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication of controlled ovarian stimulation of gonadotrophin-Stimulated ovarian cycles.
- Trial name
- NCT07043322
- Testing
- Coasting, Cabergoline
- Where
- Egypt
- Volunteers
- 150 people
- Sponsor
- Tanta University
Infertility, Female, Ovulation Induction
Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist in Controlled Ovarian Stimulation for In Vitro Fertilization: A Randomized Controlled Non-Inferiority Trial With a Concurrent Comparator Cohort Undergoing Progestin-Primed Ovarian Stimulation (PPOS)
Women undergoing IVF/ICSI who are candidates for a GnRH-antagonist protocol are randomly assigned 1:1 to oral linzagolix or the standard injectable GnRH antagonist (ganirelix or cetrorelix).
- Trial name
- NCT07732348
- Testing
- Ganirelix ; Cetrorelix, Medroxyprogesterone Acetate ; Micronized Progesterone, Linzagolix
- Volunteers
- 120 people
- Sponsor
- Centro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)
Ovarian Hyper Stimulation Syndrome (OHSS)
Ovarian Hyperstimulation Syndrome Prevention
Ovarian hyperstimulation is a very hazardous complication of ICSI
- Trial name
- OHSS (NCT06739759)
- Testing
- Antagonist protocol for IVF, Modified Agonist protocol for IVF with additive treatments as HCQ
- Where
- 2 sites in Egypt
- Volunteers
- 300 people
- Sponsor
- Aljazeera Hospital